Brian Pharmaceuticals Inc. renamed Hygenics Pharmaceuticals Inc.; company also establishes research advisory and product development committees.LAGUNA HILLS La·gu·na Hills A city of southern California southeast of Santa Ana. Population: 33,600. , Calif.--(BUSINESS WIRE)--Feb. 22, 1995--Brian Pharmaceuticals Inc. Wednesday announced that the corporate name for its public parent company, Diversified Food Manufacturers Ltd. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :DFMDV) has been changed to Hygenics Pharmaceuticals Inc. Company Chairman and Chief Executive Officer John S. Budd said the change was made to reflect more closely the company's principal business, which is to develop and market for the health care professional and consumer markets, innovative topical antimicrobials for the prevention of infection and disease. Hygenics Pharmaceuticals President and Chief Operating Officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. , Charles H. Newman, said the company has established research advisory and product development committees. The research advisory committee will bring together global academic experts in infections and microorganisms who will advise the company in the development of new antimicrobial agents Antimicrobial agents Chemical compounds biosynthetically or synthetically produced which either destroy or usefully suppress the growth or metabolism of a variety of microscopic or submicroscopic forms of life. . It will be headed by Dr. Stephen White, a professor at UCI UCI University of California, Irvine UCI Union Cycliste Internationale (International Cycling Union) UCI Unidad de Cuidados Intensivos UCI United Cinemas International (UK) medical school and president- elect of the Biophysical Society, whose members are biotechnology researchers from around the world. The company's product development committee, also chaired by Dr. White, will be comprised of physicians, dentists and podiatrists who face infection problems daily in their practices. They will advise the company about the changing nature of infections and review new Hygenics products developed to prevent infection and disease and also to recommend new products. Newman, who founded Brian Pharmaceuticals, is a veteran of more than 30 years in the pharmaceutical industry. He developed many sterile products for E.R. Squibb & Sons during his 19 years with that company, and rose to become its associate director of quality. Newman also was director of quality at Stuart Pharmaceuticals. He formulated BrianCare, a Hygenics Pharmaceuticals product, and wrote its abbreviated new drug application abbreviated new drug application Pharmacology An application made in the US by a pharmaceutical company requesting authority to market a 'new' drug for which both its therapeutic indications and formulation were previously approved by the FDA in another similar , which was approved by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. . Newman has been a consultant to Stackhouse Associates, Micro-Aire, Aprex and the Salk Institute Biotechnology Industrial Associates, among other companies. He was a member of the Pharmaceutical Manufacturers Association Quality Control Executive Committee, and served on the revision committee of the National Formulary National Formulary /Na·tion·al For·mu·lary/ (NF) a book of standards for certain pharmaceuticals and preparations that are not included in the USP(United States Pharmacopeia). Na·tion·al Formulary n. Abbr. of the United States Pharmacopaea. Hygenics Pharmaceuticals develops and markets, for the health care professional and consumer markets, innovative topical antimicrobials for the prevention of infection and disease. CONTACT: Hygenics Pharmaceuticals Inc. John Budd, 714/582-7644 or Woodbridge & Associates 800/446-6006 or 714/251-3436 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion